Trader notes, earnings previews, Confluences, weekly digests and roundups — long-form analysis grounded in ORTEX short interest, options flow and analyst data.
Trader Note — 15017 total
DECK just delivered one of its cleanest earnings beats in recent memory — and the pre-earnings bears are paying for it. The stock jumped 8.6% on May 21 following fiscal Q4 results, then added another 4.5% on Tuesday to…
Darden Restaurants enters the final stretch before its June 18 Q4 earnings with the short rebuild that began in mid-April still intact — and the stock's 5% weekly gain doing little to shake the bears loose. The short…
Danaher enters the back half of May with something it has lacked for most of the year: fresh analyst support. Citigroup reinstated coverage with a Buy and a $230 target on May 27. That follows RBC Capital doing the…
CNX Resources heads into the back end of May with the stock off 7% on the week and a persistent analyst consensus pointing to limited upside from here. The analyst picture is unusually bearish for a stock of this size.…
Churchill Downs Incorporated has spent May rewinding a sharp post-earnings rally, with shorts rebuilding at the fastest monthly pace in the data window and options tilting defensively — the clearest tension in the…
Chevron has reversed course sharply since the earnings release on May 27, with the stock falling 6.4% on the week to $184.71 — erasing almost the entire pre-earnings rally and leaving the stock fractionally below where…
Carnival Corporation has staged a sharp reversal this week, and the positioning data confirms the mood has shifted materially from the defensive crouch documented just days ago. The stock gained 11.8% on the week to…
CSX Corporation heads into the final week of May with options traders the most bullishly positioned they have been in months — while short sellers quietly reduce exposure and analysts lift targets. The shift in options…
Boston Scientific heads into the summer with a notable divide: directors bought the stock on the dip last week while short sellers have quietly doubled their position over the past month. The insider angle is the…
BXP, Inc. heads into the summer with shorts unwinding and analysts pruning their price targets, creating a pull between improving near-term positioning and a Street that still sees limited upside. Short interest has…
BWA is up 21% in a month, touched a new 52-week high this week, and just announced a $100 million factory expansion in North Carolina. The tension: every senior executive who could sell has been selling. The insider…
BA has stabilised after last week's sharp sell-off, gaining 1.8% on the week to $218.90 — but the more interesting development is happening in the options market, where sentiment has shifted more decisively toward…
BioCryst Pharmaceuticals enters late May with short sellers holding a firm grip — and the cost to maintain that position just jumped sharply. Short interest is running near 18% of the free float, a level that has…
Best Buy heads into its Q1 2026 results on May 28 with the stock up 6.6% on the week but short sellers refusing to blink — a genuine tension between price momentum and still-elevated bearish positioning. Short interest…
BNS heads into the post-earnings session having delivered exactly what income investors were looking for: a Q2 beat and a dividend raise that arrived on the same morning shorts were quietly building positions to a…
BMO enters the post-earnings stretch with shorts nearly gone, borrow costs at rock bottom, and the stock nudging a 52-week high — the question now is whether the valuation re-rating has further to run. The positioning…
Bank of America closes the week on a very different note from the last: up 3% to $52.20, reversing the month-long grind lower flagged in the prior note and narrowing — though not closing — the gap to analyst…
AutoZone delivered its fiscal Q3 results on May 26 and the market's verdict was swift: the stock dropped 9% the next day to $3,100, extending a monthly decline that now stands at 13%. The analyst response has been…
Applied Materials has surged into a fork in the road: an 11.8% weekly rally to $454.89 has reignited bullish conviction across the Street, yet one bellwether firm just stepped to the sidelines at the very moment…
Amgen heads into the summer with a quietly shifting setup — options traders are more cautious than they've been in months, short interest has been creeping higher for weeks, and the analyst community is clustered just…
